Skip to main content

Table 1 Baseline clinical and pathological characteristics of the 24 patients enrolled in the study

From: Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour

Characteristic

Number (%)

Gender

 Female

8 (33)

 Male

16 (67)

Primary tumour site

 Stomach

8 (33)

 Small bowel

13 (54)

 Rectum

2 (8)

 Unknown

1 (4)

Histological subtype

 Spindle cell

17 (71)

 Epitheloid

1 (4)

 Mixed

3 (13)

 ND

3

Mutation analysis

 KIT exon 11

18 (75)

 KIT exon 9

2 (8)

 PDGFRA exon 12

1 (4)

 Mutations not detected

2 (8)

 ND

1

Metastatic site

 Liver

13 (54)

 Intraperitoneal cavity

7 (29)

 Liver + intraperitoneal cavity

3 (13)

 No metastasis (inoperable primary tumour)

1 (4)

  1. ND not determined